Chronic pain affects approximately 100 million U.S. adults at a cost of up to $635 billion annually in direct medical costs and lost productivity.  As clinicians attempt to reduce pain and improve functionality in patients with chronic pain, pharmacotherapy remains a cornerstone of treatment. Typically, several medications with different mechanisms of action are employed toContinue reading “Pharmacogenetics and pain management by Maria Chianta and Maria Guevara PharmDs”